Short Interest in Novozymes A/S (OTCMKTS:NVZMY) Rises By 176.9%

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 3,600 shares, an increase of 176.9% from the February 29th total of 1,300 shares. Based on an average daily volume of 27,700 shares, the days-to-cover ratio is presently 0.1 days.

Novozymes A/S Stock Down 0.8 %

OTCMKTS NVZMY traded down $0.50 during trading hours on Thursday, reaching $58.85. 5,666 shares of the company’s stock were exchanged, compared to its average volume of 13,332. The company’s 50-day moving average is $55.56 and its two-hundred day moving average is $50.64. Novozymes A/S has a one year low of $38.75 and a one year high of $61.86. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.80 and a current ratio of 1.30. The company has a market capitalization of $27.56 billion, a price-to-earnings ratio of 37.56, a price-to-earnings-growth ratio of 4.04 and a beta of 0.82.

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) last posted its earnings results on Wednesday, January 31st. The biotechnology company reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.11). Novozymes A/S had a return on equity of 21.42% and a net margin of 16.88%. The business had revenue of $664.46 million for the quarter. On average, analysts forecast that Novozymes A/S will post 1.93 EPS for the current fiscal year.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Further Reading

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.